There were 1,730 press releases posted in the last 24 hours and 405,523 in the last 365 days.

Human medicines European public assessment report (EPAR): Trepulmix, treprostinil, Hypertension, Pulmonary, Date of authorisation: 03/04/2020, Revision: 4, Status: Authorised

The most common side effects with Trepulmix (which may affect more than 1 in 10 people) are headache, widening of blood vessels (with flushing), diarrhoea, nausea (feeling sick), jaw pain, reactions around the injection site such as pain, swelling and bleeding.

Trepulmix must not be used in patients with conditions like heart problems, stroke, problems in the gut such as ulcers, blocked veins in lungs and severe liver problems. Patients must not take Trepulmix at the same time as similar medicines called prostanoids.

For the full list of side effects and restrictions of Trepulmix, see the package leaflet.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.